Atlas Trials

Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis

Clinical trial NCT04265092 · COMPLETED

Trial details

NCT number
NCT04265092
Sponsor
Pôle Saint Hélier
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2014-01-01
Primary completion
2014-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.